February 2025 in “PubMed” Thorough scalp exams are crucial for diagnosing hair loss conditions in people with skin of color.
January 2025 in “Journal of medical & health sciences review.” Hormonal imbalances and genetics are key in familial hirsutism.
January 2025 in “International Journal of Pharmaceutics” A new gel improves hair loss treatment by effectively delivering minoxidil and finasteride to the scalp.
January 2025 in “The Pharma Innovation” Nanospanlastic vesicles can improve glaucoma treatment by enhancing drug delivery to the eye.
January 2025 in “ANNALS OF PAKISTAN MEDICAL & ALLIED PROFESSIONALS” Insulin resistance is common and linked to high male hormones in Pakistani women with PCOS.
January 2025 in “BioMed Research International” Targeting DNA methylation can help treat skin disorders and cancers.
January 2025 in “Nanoscale Advances” The study presents a biocompatible nanocomposite, ZnO@PDA@Ag@9-Br-Nos, designed for enhanced lung cancer therapy. This nanocomposite, which incorporates the hydrophobic anticancer drug 9-bromonoscapine, demonstrated efficient drug loading (69.4%) and sustained release at physiological pH. Characterization confirmed its stability and functional integrity. In vitro tests showed significant cytotoxicity against H1299 lung cancer cells with an IC50 of 33.51±4.54 µg/mL, while maintaining non-toxicity to normal cells and human erythrocytes. These results suggest that ZnO@PDA@Ag@9-Br-Nos is a promising nanocarrier for targeted cancer treatment, warranting further investigation for translational applications.
December 2024 in “Medical Review” Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.
November 2024 in “Comparative Biochemistry and Physiology Part D Genomics and Proteomics” Exosomes help hair follicle development in cashmere goats.
October 2024 in “Aesthetic Plastic Surgery” Micrografts are a safe and effective treatment for hair loss in both men and women.